Home
Team
Portfolio
Blog
Contact
Investors
More
Our Recent Posts
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
RevLocal Acquired by Hibu, an H.I.G. Capital Portfolio Company
Archive
AAHKS Names OrthAlign, Inc. as the 2023 Industry Innovation Award Winner
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
7SIGNAL Appoints Enterprise Mobility and Software Leader Sebastian Shahvandi as New CEO